19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2015

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: Clinical results and biological observations in taxane-pretreated patients

Fabi, A., Giannarelli, D., Malaguti, P., Ferretti, G., Vari, S., Papaldo, P., Nisticò, C., Caterino, M., De Vita, R., Mottolese, M., Iacorossi, L. & Cognetti, F., Nov 20 2015, In : Drug Design, Development and Therapy. 9, p. 6177-6183 7 p.

Research output: Contribution to journalArticle

The promher study: An observational Italian study on adjuvant therapy for her2-positive, pT1a-b pN0 breast cancer

Gori, S., Inno, A., Fiorio, E., Foglietta, J., Ferro, A., Gulisano, M., Pinotti, G., Gubiotti, M., Cavazzini, M. G., Turazza, M., Duranti, S., De Simone, V., Iezzi, L., Bisagni, G., Spazzapan, S., Cavanna, L., Saggia, C., Bria, E., Cretella, E., Vici, P. & 16 others, Santini, D., Fabi, A., Garrone, O., Frassoldati, A., Amaducci, L., Saracchini, S., Evangelisti, L., Barni, S., Gamucci, T., Mentuccia, L., Laudadio, L., Zoboli, A., Marchetti, F., Bogina, G., Lunardi, G. & Boni, L., Sep 4 2015, In : PLoS One. 10, 9, e0136731.

Research output: Contribution to journalArticle

The role of PET [18F]FDOPA in evaluating low-grade glioma

Villani, V., Carapella, C. M., Chiaravalloti, A., Terrenato, I., Piludu, F., Vidiri, A., Schillaci, O., Floris, R., Marzi, S., Fabi, A. & Pace, A., Sep 1 2015, In : Anticancer Research. 35, 9, p. 5117-5122 6 p.

Research output: Contribution to journalArticle

2014

Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas

Vaccaro, V., Fabi, A., Vidiri, A., Giannarelli, D., Metro, G., Telera, S., Vari, S., Piludu, F., Carosi, M. A., Villani, V., Cognetti, F., Pompili, A., Marucci, L., Carapella, C. M. & Pace, A., 2014, In : BioMed Research International. 2014, 351252.

Research output: Contribution to journalArticle

Eribulin mesylate in pretreated breast cancer patients: A multicenter retrospective observational study

Gamucci, T., Michelotti, A., Pizzuti, L., Mentuccia, L., Landucci, E., Sperduti, I., Di Lauro, L., Fabi, A., Tonini, G., Sini, V., Salesi, N., Ferrarini, I., Vaccaro, A., Pavese, I., Veltri, E., Moscetti, L., Marchetti, P. & Vici, P., 2014, In : Journal of Cancer. 5, 5, p. 320-327 8 p.

Research output: Contribution to journalArticle

Safety and efficacy of bevacizumab in combination with first-line chemotherapy in advanced breast cancer: Data from the Italian cohort of the ATHENA trial

Sanna, G., Fabi, A., Crivellari, D., Saracchini, S., Battelli, N., Nisticò, C., Capobianco, A. M., Zampa, G., Bottini, A., Del Prete, S., Simoncini, E., Galli, A., Matasconi, M., Restuccia, E. & Biganzoli, L., Jul 1 2014, Tumori. 4 ed. Il Pensiero Scientifico Editore s.r.l., Vol. 100. p. 432-438 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Weight of epilepsy in brain tumor patients

Maschio, M., Sperati, F., Dinapoli, L., Vidiri, A., Fabi, A., Pace, A., Pompili, A., Carapella, C. M. & Cantelmi, T., 2014, In : Journal of Neuro-Oncology. 118, 2, p. 385-393 9 p.

Research output: Contribution to journalArticle

2013

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: The COSTANza study

Lazzaro, C., Bordonaro, R., Cognetti, F., Fabi, A., De Placido, S., Arpino, G., Marchetti, P., Botticelli, A., Pronzato, P. & Martelli, E., Apr 9 2013, In : ClinicoEconomics and Outcomes Research. 5, 1, p. 125-135 11 p.

Research output: Contribution to journalArticle

An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting

Fabi, A. & Malaguti, P., Apr 2013, In : Expert Opinion on Pharmacotherapy. 14, 5, p. 629-641 13 p.

Research output: Contribution to journalArticle

Effect of adjuvant trastuzumab treatment in conventional clinical setting: An observational retrospective multicenter Italian study

Campiglio, M., Bufalino, R., Sasso, M., Ferri, E., Casalini, P., Adamo, V., Fabi, A., Aiello, R., Riccardi, F., Valle, E., Scotti, V., Tabaro, G., Giuffrida, D., Tarenzi, E., Bologna, A., Mustacchi, G., Bianchi, F., Balsari, A., Ménard, S. & Tagliabue, E., Aug 2013, In : Breast Cancer Research and Treatment. 141, 1, p. 101-110 10 p.

Research output: Contribution to journalArticle

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer

Fabi, A., Merola, R., Ferretti, G., Di Benedetto, A., Antoniani, B., Ercolani, C., Nisticò, C., Papaldo, P., Ciccarese, M., Sperduti, I., Vici, P., Marino, M., Gori, S., Botti, C., Malaguti, P., Cognetti, F. & Mottolese, M., Apr 2013, In : Expert Opinion on Pharmacotherapy. 14, 6, p. 699-706 8 p.

Research output: Contribution to journalArticle

L'importanza di un percorso di riabilitazione cognitiva nel paziente con epilessia tumorale con deficit neurocognitivi

Translated title of the contribution: The importance of a cognitive rehabilitation program in patients with brain tumor-related epilepsy and cognitive deficitsMaschio, M., Dinapoli, L., Fabi, A., Pace, A. & Giannarelli, D., Apr 2013, In : Bollettino - Lega Italiana contro l'Epilessia. 145, p. 55-58 4 p.

Research output: Contribution to journalArticle

Radionecrosis induced by stereotactic radiosurgery of brain metastases: Results of surgery and outcome of disease

Telera, S., Fabi, A., Pace, A., Vidiri, A., Anelli, V., Carapella, C. M., Marucci, L., Crispo, F., Sperduti, I. & Pompili, A., Jun 2013, In : Journal of Neuro-Oncology. 113, 2, p. 313-325 13 p.

Research output: Contribution to journalArticle

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: A comparison of different schedules and treatments

Del Mastro, L., Fabi, A., Mansutti, M., De Laurentiis, M., Durando, A., Merlo, D. F., Bruzzi, P., La Torre, I., Ceccarelli, M., Kazeem, G., Marchi, P., Boy, D., Venturini, M., De Placido, S. & Cognetti, F., Mar 28 2013, In : BMC Cancer. 13, 164.

Research output: Contribution to journalArticle

Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancer

Pacetti, U., Veltri, E., Fattoruso, S. I. S., Cardillo, F. D. A., Evangelista, S., Cognetti, F. & Fabi, A., Apr 2013, In : Anticancer Research. 33, 4, p. 1721-1724 4 p.

Research output: Contribution to journalArticle

The mammalian target of rapamycin inhibitors in breast cancer: Current evidence and future directions

Malaguti, P., Vari, S., Cognetti, F. & Fabi, A., Jan 2013, In : Anticancer Research. 33, 1, p. 21-28 8 p.

Research output: Contribution to journalArticle

2012

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer

Minuti, G., Cappuzzo, F., Duchnowska, R., Jassem, J., Fabi, A., Obrien, T., Mendoza, A. D., Landi, L., Biernat, W., Czartoryska-Arukowicz, B., Jankowski, T., Zuziak, D., Zok, J., Szostakiewicz, B., Foszczyska-Koda, M., Tempiska-Szaach, A., Rossi, E. & Varella-Garcia, M., Aug 21 2012, In : British Journal of Cancer. 107, 5, p. 793-799 7 p.

Research output: Contribution to journalArticle

Lacosamide come antiepilettico in add-on in pazienti affetti da epilessia secondaria a tumore cerebrale

Translated title of the contribution: Add-on lacosamide in brain tumor-related epilepsy. Preliminary report: Efficacy and tolerabilityDinapoli, L., Maschio, M., Mingoia, M., Sperati, F., Fabi, A., Pace, A., Petreri, G. & Muti, P., May 2012, In : Bollettino - Lega Italiana contro l'Epilessia. 144, p. 195-197 3 p.

Research output: Contribution to journalArticle

Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: A case report and review of literature

Onesti, E., Fabi, A., Mingoia, M., Savarese, A., Anelli, V. & Koudriavtseva, T., Sep 2012, In : Clinical Neurology and Neurosurgery. 114, 7, p. 1081-1085 5 p.

Research output: Contribution to journalArticle

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: Efficacy in combination with hormonal therapy

Fabi, A., Russillo, M., Ferretti, G., Metro, G., Nisticò, C., Papaldo, P., De Vita, F., D'Auria, G., Vidiri, A., Giannarelli, D. & Cognetti, F., Oct 19 2012, In : BMC Cancer. 12, 482.

Research output: Contribution to journalArticle

New target therapies for brain metastases from breast cancer

Metro, G. & Fabi, A., Mar 2012, In : Current Cancer Drug Targets. 12, 3, p. 210-217 8 p.

Research output: Contribution to journalArticle

Perfusion Computed Tomography (PCT) adopting different perfusion metrics: Recurrence of brain metastasis or radiation necrosis?

Vidiri, A., Guerrisi, A., Pinzi, V., Fabi, A., Mirri, M. A., Pompili, A., Caporale, N., Pace, A., Crecco, M. & Marzi, S., Jun 2012, In : European Journal of Radiology. 81, 6, p. 1246-1252 7 p.

Research output: Contribution to journalArticle

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

Gori, S., Montemurro, F., Spazzapan, S., Metro, G., Foglietta, J., Bisagni, G., Ferzi, A., Silva, R. R., Gamucci, T., Clavarezza, M., Stocchi, L., Fabi, A., Cognetti, F., Torrisi, E. & Crivellari, D., 2012, In : Annals of Oncology. 23, 6, p. 1436-1441 6 p.

Research output: Contribution to journalArticle

The Italian cross-sectional survey of the management of bonemetastasis: ZeTa study

Santini, D., Bertoldo, F., Dell'Aquila, E., Cecchini, I., Fregosi, S., Bortolussi, P., Airoldi, M., Allegrini, G., Amoroso, D., Amoroso, V., Astone, A., Barni, S., Bighin, C., Boccardo, F., Bonetti, A., Borsellino, N., Bretti, S., Buosi, R., Butera, A., Caroti, C. & 51 others, Carteni, G., Cascinu, S., Cinieri, S., Clerico, M., Contu Antonio, S., Danova, M., Dell'Aquila, E., Delprete, S., Dicristina, L., Fabi, A., Faggiuolo, R., Falcone, A., Fava, S., Febbraro, A., Ferretti, B., Gebbia, V., Giordano, M., Giotta, F., Giustini, L., Guaraldi, M., Ibrahim, T., Lanzetta, G., Leo, L., Lorusso, V., Maestri, A., Maiello, E., Mansutti, M., Manzione, L., Massidda, B., Mazzuca, F., Montesarchio, V., Moscetti, L., Ortu, S., Pasini, F., Piga, A., Pinotti, G., Romito, S., Rosti, G., Sabbatini, R., Salvagni, S., Savastano, C., Scapoli, D., Silva, R., Testa, A., Tondini, C., Vaccaro, A., Valenza, R., Valerio, M., Verusio, C., Zagonel, V. & Zampa, G., Sep 2012, In : Journal of Bone Oncology. 1, 2, p. 35-39 5 p.

Research output: Contribution to journalArticle

2011

Assessment of PTEN and PI3K status in primary breast cancer and corresponding metastases: Is it worthwhile?

Russillo, M., Di Benedetto, A., Metro, G., Ferretti, G., Papaldo, P., Cognetti, F., Mottolese, M. & Fabi, A., Jul 10 2011, In : Journal of Clinical Oncology. 29, 20, p. 2834-2835 2 p.

Research output: Contribution to journalArticle

Brain metastases from solid tumors: Disease outcome according to type of treatment and therapeutic resources of the treating center

Fabi, A., Felici, A., Metro, G., Mirri, A., Bria, E., Telera, S., Moscetti, L., Russillo, M., Lanzetta, G., Mansueto, G., Pace, A., Maschio, M., Vidiri, A., Sperduti, I., Cognetti, F. & Carapella, C. M., 2011, In : Journal of Experimental and Clinical Cancer Research. 30, 1, 10.

Research output: Contribution to journalArticle

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Metro, G., Foglietta, J., Russillo, M., Stocchi, L., Vidiri, A., Giannarelli, D., Crinò, L., Papaldo, P., Mottolese, M., Cognetti, F., Fabi, A. & Gori, S., Mar 2011, In : Annals of Oncology. 22, 3, p. 625-630 6 p.

Research output: Contribution to journalArticle

Eritema multiforme durante radioterapia in 4 pazienti con epilessia secondaria a neoplasia cerebrale in monoterapia con oxcarbazepina

Translated title of the contribution: Multiform erythema in epileptic patients on radiotherapy for brain tumor and treated with oxcarbazepineMaschio, M., Dinapoli, L., Fabi, A., Pace, A., Vidiri, A. & Muti, P., Apr 2011, In : Bollettino - Lega Italiana contro l'Epilessia. 142, p. 167-169 3 p.

Research output: Contribution to journalArticle

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: Safety and efficacy in an open-label study in 2251 patients

Smith, I. E., Pierga, J. Y., Biganzoli, L., Cortés-Funes, H., Thomssen, C., Pivot, X., Fabi, A., Xu, B., Stroyakovskiy, D., Franke, F. A., Kaufman, B., Mainwaring, P., Pienkowski, T., de Valk, B., Kwong, A., González-Trujillo, J. L., Koza, I., Petrakova, K., Pereira, D. & Pritchard, K. I., Mar 2011, In : Annals of Oncology. 22, 3, p. 595-602 8 p.

Research output: Contribution to journalArticle

HER2 protein and gene variation between primary and metastatic breast cancer: Significance and impact on patient care

Fabi, A., Di Benedetto, A., Metro, G., Perracchio, L., Nisticò, C., Di Filippo, F., Ercolani, C., Ferretti, G., Melucci, E., Buglioni, S., Sperduti, I., Papaldo, P., Cognetti, F. & Mottolese, M., Apr 1 2011, In : Clinical Cancer Research. 17, 7, p. 2055-2064 10 p.

Research output: Contribution to journalArticle

Levetiracetam monotherapy in patients with brain tumor-related epilepsy: Seizure control, safety, and quality of life

Maschio, M., Dinapoli, L., Sperati, F., Pace, A., Fabi, A., Vidiri, A. & Muti, P., Aug 2011, In : Journal of Neuro-Oncology. 104, 1, p. 205-214 10 p.

Research output: Contribution to journalArticle

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Cuppone, F., Bria, E., Vaccaro, V., Puglisi, F., Fabi, A., Sperduti, I., Carlini, P., Milella, M., Nisticò, C., Russillo, M., Papaldo, P., Ferretti, G., Aapro, M., Giannarelli, D. & Cognetti, F., 2011, In : Journal of Experimental and Clinical Cancer Research. 30, 1, 54.

Research output: Contribution to journalArticle

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: A phase II study

Rozzi, A., Nardoni, C., Corona, M., Restuccia, M. R., Fabi, A., Bria, E., Minniti, G. & Lanzetta, G., May 2011, In : Supportive Care in Cancer. 19, 5, p. 697-701 5 p.

Research output: Contribution to journalArticle

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: A randomized, multicenter, phase III trial

Celio, L., Frustaci, S., Denaro, A., Buonadonna, A., Ardizzoia, A., Piazza, E., Fabi, A., Capobianco, A. M., Isa, L., Cavanna, L., Bertolini, A., Bichisao, E. & Bajetta, E., Aug 2011, In : Supportive Care in Cancer. 19, 8, p. 1217-1225 9 p.

Research output: Contribution to journalArticle

Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines

Vici, P., Fabi, A., Metro, G., Sergi, D., Giannarelli, D., Di Lauro, L., Bepler, G., Tomao, F., Cognetti, F., Conti, F. & Lopez, M., Mar 2011, In : Cancer Chemotherapy and Pharmacology. 67, 3, p. 687-693 7 p.

Research output: Contribution to journalArticle

2010

Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

Fabi, A., Metro, G., Di Benedetto, A., Nisticò, C., Vici, P., Melucci, E., Antoniani, B., Perracchio, L., Sperduti, I., Milella, M., Cognetti, F. & Mottolese, M., Apr 2010, In : Oncology. 78, 2, p. 141-149 9 p.

Research output: Contribution to journalArticle

Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease

Ferretti, G., Fabi, A., Felici, A. & Papaldo, P., Jul 10 2010, In : Journal of Clinical Oncology. 28, 20

Research output: Contribution to journalArticle

In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy

Metro, G., Zheng, Z., Fabi, A., Schell, M., Antoniani, B., Mottolese, M., Monteiro, A. N., Vici, P., Rivera, S. L., Boulware, D., Cognetti, F. & Bepler, G., 2010, In : Cancer Investigation. 28, 2, p. 172-180 9 p.

Research output: Contribution to journalArticle

Low-dose fotemustine for recurrent malignant glioma: A multicenter phase II study

Fabi, A., Metro, G., Vidiri, A., Lanzetta, G., Carosi, M., Telera, S., Maschio, M., Russillo, M., Sperduti, I., Carapella, C. M., Cognetti, F. & Pace, A., Nov 2010, In : Journal of Neuro-Oncology. 100, 2, p. 209-215 7 p.

Research output: Contribution to journalArticle

Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

Metro, G., Fabi, A., Mirri, M. A., Vidiri, A., Pace, A., Carosi, M., Russillo, M., Maschio, M., Giannarelli, D., Pellegrini, D., Pompili, A., Cognetti, F. & Carapella, C. M., Jan 2010, In : Cancer Chemotherapy and Pharmacology. 65, 2, p. 391-397 7 p.

Research output: Contribution to journalArticle

Supportive care in neurooncology

Pace, A., Metro, G. & Fabi, A., Nov 2010, In : Current Opinion in Oncology. 22, 6, p. 621-626 6 p.

Research output: Contribution to journalArticle

Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancer

Metro, G., Giannarelli, D., Gemma, D., Lanzetta, G., Ciccarese, M., Papaldo, P., Gamucci, T., Lorusso, V., Mottolese, M., Magnolfi, E., Cognetti, F. & Fabi, A., Jan 2010, In : Breast Journal. 16, 1, p. 66-72 7 p.

Research output: Contribution to journalArticle

2009

Pseudoprogression and MGMT status in glioblastoma patients: Implications in clinical practice

Fabi, A., Russillo, M., Metro, G., Vidiri, A., Di Giovanni, S. & Cognetti, F., Jul 2009, In : Anticancer Research. 29, 7, p. 2607-2610 4 p.

Research output: Contribution to journalArticle